LAVAL, Quebec, Oct. 3, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) (“Valeant”) will release its third-quarter 2017 financial results on Tuesday, Nov. 7, 2017. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.
Conference Call Details
Date: | Tuesday, Nov. 7, 2017 |
Time: | 8:00 a.m. EST |
Webcast: | |
Participant Event Dial-in: | (844) 428-3520 (North America) |
(409) 767-8386 (International) | |
Participant Passcode: | 91700211 |
Replay Dial-in: | (855) 859-2056 (North America) |
(404) 537-3406 (International) | |
Replay Passcode: | 91700211 (replay available until Jan. 7, 2018) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Investor Contact: | Media Contact: |
Arthur Shannon | Lainie Keller |
(514) 856-3855 | (908) 927-0617 |
(877) 281-6642 (toll free) |
View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-will-release-third-quarter-2017-financial-results-on-november-7-300528475.html
SOURCE Valeant Pharmaceuticals International, Inc.
